Feasibility and Acceptability of the Informant AD8 for Cognitive Screening in Primary Healthcare: A Pilot Study

YanHong Dong, Tuck Seng Cheng, Keith Yu Kei Tsou, Qun Lin Chan, Christopher ChenThe Scientific World JOURNAL 2014 · DOI

TL;DR

This pilot study investigated the feasibility and acceptability of the Informant AD8, a brief screening tool for cognitive impairment, in a primary healthcare setting in Singapore. The findings suggest the AD8 is a practical and well-tolerated instrument that can effectively identify a significant proportion of older adults with potential cognitive issues, making it a valuable tool for early case finding in primary care.

What Problem Does This Paper Address?

Dementia is a growing global health concern, with a significant portion of cases remaining unrecognized, particularly in primary healthcare settings. This lack of early detection hinders timely intervention and support for affected individuals and their families. While several brief cognitive screening instruments exist, their utility and suitability for routine use in busy primary care clinics, especially in diverse populations like Singapore, remain underexplored. This paper specifically addresses the gap in understanding the feasibility and acceptability of the Informant AD8, an informant-based tool, within this critical primary care context.

Methods

The study employed a pilot design to evaluate the Informant AD8's performance in a primary healthcare clinic in Singapore.

  • Participants: Older adults (aged 60 and above) attending a "Chronic Illness" clinic were recruited, along with their informants who had sufficient language proficiency.
  • Instrument: The Informant AD8, an eight-item questionnaire assessing functional decline attributed to cognitive impairment, was administered. It uses a simple "yes/no" format and takes approximately 3 minutes to complete. A score of 2 or higher was considered indicative of cognitive impairment.
  • Data Collection: Informants completed the AD8 either independently, with assistance from a research psychologist, or over the phone. Data on administration time, demographic characteristics, and feedback on acceptability from informants and primary care physicians were collected.
  • Referral Process: Patients identified as screen-positive (AD8 score ≥ 2) were referred to specialist memory clinics. Referral rates and reasons for declining referrals were documented.
  • Statistical Analysis: Descriptive statistics were used to assess acceptability, and independent-sample t-tests and chi-square tests were employed for between-group comparisons. Logistic regression was used to identify predictors of screen positivity.

Datasets

Not discussed in the paper. The study utilized data collected directly from participants and their informants during the pilot study.

Key Insights and Ideas

  • Informant AD8's Practicality: The study highlights that the Informant AD8 is not only quick to administer (average 2.7 minutes) but also adaptable to different modes of delivery (in-person, phone), making it suitable for busy primary care environments.
  • High Acceptability: Both informants and primary care physicians found the AD8 to be acceptable and user-friendly, suggesting it can be integrated into routine clinical workflows without significant burden.
  • Significant Detection Rate: The AD8 successfully identified cognitive impairment in a substantial proportion (nearly one-third) of older adults attending primary care, underscoring its potential for early case finding.
  • Insight Gap as a Barrier: A key finding is that a significant number of referrals were declined due to a lack of insight into the implications of cognitive impairment by patients and/or their informants, indicating a broader challenge beyond just screening.
  • Informant Role is Crucial: The study reinforces the importance of informants in identifying cognitive changes, as their input significantly predicted screen-positive results.

Key Results

  • Recruitment: 205 patients and their informants were recruited.
  • Feasibility: The AD8 was efficiently administered, with most informants available for screening. A significant portion (over half) of informants required some assistance, while a third could complete it over the phone, and a quarter independently.
  • Screening Performance: Approximately one-third of patients (59 out of 199, 29.6%) screened positive for cognitive impairment (AD8 ≥ 2).
  • Referral Outcomes: A substantial majority of screen-positive patients (58.3%) were not referred to a specialist memory clinic by their primary care physicians. Of those referred, a large proportion (41.7%) declined the referral, primarily due to limited insight into cognitive impairment. Only a small minority (18.6%) accepted the referral, and of those, a third attended a memory clinic, with one patient diagnosed with cognitive impairment and two with dementia.
  • Physician Feedback: All five primary care physicians who completed the satisfaction survey found the AD8 helpful in facilitating referrals to specialist memory clinics.

Limitations and Future Work

  • Limitations:
    • The study used the established AD8 cutoff score rather than formal neuropsychological testing or clinical evaluation to define cognitive impairment.
  • The screening was conducted over a short period in a single primary healthcare clinic, limiting generalizability.
  • A significant number of patients were excluded due to the lack of an informant, suggesting a need for informant-independent screening tools for this group.
  • The study did not explore the reasons for primary care physicians not referring screen-positive patients or why patients who accepted referrals did not attend.
  • Future Work:
    • Future studies should validate the AD8 against formal neuropsychological assessments and clinical diagnoses.
  • Larger, multi-clinic studies are needed to improve generalizability.
  • Investigating performance-based brief tests for patients without informants is recommended.
  • Further research should explore the barriers to referral by primary care physicians and the reasons for non-attendance at memory clinics.

Summary updated

Abstract

The AD8 can be easily administered and is well tolerated. It detected cognitive impairment in one-third of older adult patients and therefore may be useful for case finding of cognitive impairment in the primary healthcare.
BibTeX
@article{dong2014feasibility,
  author = {YanHong Dong and Tuck Seng Cheng and Keith Yu Kei Tsou and Qun Lin Chan and Christopher Chen},
  title = {{Feasibility and Acceptability of the Informant AD8 for Cognitive Screening in Primary Healthcare: A Pilot Study}},
  journal = {The Scientific World JOURNAL},
  year = {2014},
  doi = {10.1155/2014/302834},
}
Figure